Bavarian Nordic Revenue and Competitors
Estimated Revenue & Valuation
- Bavarian Nordic's estimated annual revenue is currently $235.8M per year.
- Bavarian Nordic's estimated revenue per employee is $155,000
Employee Data
- Bavarian Nordic has 1521 Employees.
- Bavarian Nordic grew their employee count by 14% last year.
Bavarian Nordic's People
Name | Title | Email/Phone |
---|---|---|
1 | Snr VP, Global Operations | Reveal Email/Phone |
2 | Biosafety Officer | Reveal Email/Phone |
3 | Head Quality Control | Reveal Email/Phone |
4 | VP, Biometrics and Clinical Operations | Reveal Email/Phone |
5 | Head Clinical Data Management | Reveal Email/Phone |
6 | VP, U.S. Government Affairs | Reveal Email/Phone |
7 | Controller | Reveal Email/Phone |
8 | Controller, Goverment Reporting | Reveal Email/Phone |
9 | VP, DP Manufacturing | Reveal Email/Phone |
10 | VP Medical Affairs | Reveal Email/Phone |
Bavarian Nordic Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Bavarian Nordic?
Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.
keywords:N/AN/A
Total Funding
1521
Number of Employees
$235.8M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bavarian Nordic News
2022-04-17 - Bavarian Nordic begins phase 3 clinical trial of MVA-BN RSV ...
A global, Phase 3 trial of approximately 20,000 older adult volunteers for the Bavarian Nordic A/S MVA-BN RSV vaccine candidate began this...
2022-04-17 - Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of
its RSV Vaccine Candidate in Older Adults
Bavarian Nordic's vaccine candidate, MVA-BN RSV, is being developed for the prevention of respiratory syncytial virus (RSV) in older adults. The...
2022-03-30 - New Incentive Programs Established for Members of ...
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $511.3M | 1660 | 1% | N/A |
#2 | N/A | 1771 | 10% | N/A |
#3 | $674.4M | 1784 | 5% | N/A |
#4 | $256.2M | 1794 | -1% | N/A |
#5 | $622.9M | 3099 | 4% | N/A |